For the quarter ending 2026-03-31, RGBPP has $260,194 in assets. $5,619,062 in debts. $271 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 271 | 4,578 | 69,555 | - |
| Accounts receivable, related party | 259,723 | 232,298 | 204,873 | - |
| Prepaid expenses | 200 | 200 | 200 | 200 |
| Cash | - | - | - | 1,761 |
| Accounts receivable, related party | - | - | - | 177,147 |
| Total current assets | 260,194 | 237,076 | 274,628 | 179,108 |
| Investment securities, related party | - | - | - | 17,733 |
| Total assets | 260,194 | 237,076 | 274,628 | 196,841 |
| Accounts payable | 20,150 | 11,024 | 1,714 | 30,477 |
| Accrued expenses | 1,985,896 | 1,852,221 | 1,838,230 | 1,774,158 |
| Notes payable-Nonrelated Party | 132,503 | - | - | 0 |
| Notes payable-Related Party | 8,926 | 132,504 | 191,339 | 266,339 |
| Unearned income | 1,275,331 | 1,306,971 | 1,338,611 | 1,370,251 |
| Derivative liability | 1,278,763 | 2,460,443 | 2,079,618 | 1,780,402 |
| Convertible notes payable, net of unamortized debt discount | 817,717 | 947,132 | 1,006,521 | 769,905 |
| Other current liabilities | 99,776 | 99,776 | 99,776 | 21,000 |
| Preferred stock, value-Series AAPreferred Stock | - | - | - | 0 |
| Total current liabilities | 5,619,062 | 6,810,073 | 6,555,811 | 6,012,532 |
| Preferred stock, value | - | - | - | 0 |
| Total liabilities | 5,619,062 | 6,810,073 | 6,555,811 | 6,012,532 |
| Common stock (.0001 par value) 5,800,000,000 authorized and 351,438,592 and 39,374,704 shares issued and outstanding, respectively | 35,144 | 10,806 | 3,939 | 3,157 |
| Preferred stock, value-Series APreferred Stock | 15,475 | 1,011 | 1,011 | 1,011 |
| Preferred stock, value-Series MPreferred Stock | 3 | 3 | 3 | 3 |
| Preferred stock, value-Series NCPreferred Stock | 2 | 2 | 2 | 2 |
| Additional paid in capital | 16,480,634 | 16,297,234 | 15,628,062 | 15,504,134 |
| Other comprehensive income | -222,580 | -222,580 | -222,580 | -204,847 |
| Retained earnings (deficit) | -21,667,546 | -22,659,473 | -21,691,620 | -21,119,151 |
| Total stockholders equity (deficit) | -5,358,868 | -6,572,997 | -6,281,183 | -5,815,691 |
| Total liabilities & stockholders equity (deficit) | 260,194 | 237,076 | 274,628 | 196,841 |
Regen BioPharma Inc (RGBPP)
Regen BioPharma Inc (RGBPP)